Document is current

Any future updates will be listed below

Rituximab-Biosimilar bei Multipler Sklerose gleich wirksam wie das Original

Crossref DOI link: https://doi.org/10.1007/s15005-020-1343-0

Published Online: 2020-05-25

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark